Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
Integrated Pharmacy Research and Practice · 2017
DOI: 10.2147/iprp.s129544 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Integrated Pharmacy Research and Practice, 2017. Verfasst von Mary Barna Bridgeman. Beteiligte Einrichtung: Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
- Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
Zitieren
APA
Bridgeman, M. B. (2017). Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis. Integrated Pharmacy Research and Practice. https://doi.org/10.2147/iprp.s129544
Vancouver
Bridgeman MB. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis. Integrated Pharmacy Research and Practice. 2017. doi:10.2147/iprp.s129544
BibTeX
@article{Bridgeman2017,
author = {Bridgeman, Mary Barna},
title = {Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis},
journal = {Integrated Pharmacy Research and Practice},
year = {2017},
doi = {10.2147/iprp.s129544}
}
EUVIMED